##fileformat=VCFv4.1
##source=VarSeqV2.5.0
##fileDate=20230918
##INFO=<ID=Type,Number=1,Type=String,Description="Type of CNV event (either Gain, Loss, or CN LoH)">
##INFO=<ID=Targets,Number=1,Type=Integer,Description="Number of targets in this event">
##INFO=<ID=Samples2,Number=1,Type=Integer,Description="Number of samples that share this event">
##INFO=<ID=Span,Number=1,Type=Integer,Description="Size of this event">
##INFO=<ID=GeneNames,Number=.,Type=String,Description="The set of unique gene names seen in all overlapping transcripts">
##INFO=<ID=GeneIDs,Number=.,Type=String,Description="The set of Entrez gene identifiers for all overlapping transcripts">
##INFO=<ID=Aliases,Number=.,Type=String,Description="Previous names for the set of genes">
##INFO=<ID=Genes,Number=1,Type=Integer,Description="The number of genes overlapping this region.">
##INFO=<ID=TranscriptNameClinicallyRelevant,Number=.,Type=String,Description="The transcript determined to be clinically relevant among those found for the variant's interaction with the gene. If the variant affects multiple genes, one transcript from each gene is selected to be clinically relevant. The clinically relevant transcript is the transcript with the longest coding sequence among the transcripts with an LRG annotation. If a gene has no transcripts that are annotated with an LRG ID, the transcript with the longest coding sequence is used. For more information on how transcripts are chosen see our <a href='http://blog.goldenhelix.com/ajesaitis/whats-in-a-name-the-intricacies-of-identifying-variants/'>blog post on the topic</a>.">
##INFO=<ID=OverlappingExonsClinicallyRelevant,Number=.,Type=String,Description="Which exons of the transcript overlapping this region, or 'All' if they all overlap. Exon numbers are always numbered from the 5' UTR to the 3' UTR.">
##INFO=<ID=HGVSg,Number=1,Type=String,Description="The associated HGVS notation using the genomic reference sequence.">
##INFO=<ID=HGVScClinicallyRelevant,Number=.,Type=String,Description="The associated HGVS coding DNA notation with the clinically relevant transcript(s).">
##INFO=<ID=HGVSpClinicallyRelevant,Number=.,Type=String,Description="The associated HGVS protein change notation with the clinically relevant transcript(s).">
##INFO=<ID=ISCNCytobandNotation,Number=1,Type=String,Description="ISCN notation describing the overlapping cytobands.">
##INFO=<ID=SequenceOntologyClinicallyRelevant,Number=1,Type=String,Description="The sequence ontology associated with the clinically relevant transcript(s).">
##INFO=<ID=RegionClinicallyRelevant,Number=1,Type=String,Description="The region in which the variant is located. When a variant overlaps multiple regions, the region with the highest precedence is given. The order of precedence is defined as (from highest to lowest): exon, utr5, utr3, intron, intergenic.">
##INFO=<ID=Region,Number=.,Type=String,Description="The genomic position of the region.">
##INFO=<ID=Span2,Number=.,Type=Integer,Description="The size of the region (Stop-Stop).">
##INFO=<ID=OverlapType,Number=1,Type=String,Description="Specifies the way in which the CNV overlaps the region. Either \"Contains Region\", \"Within Region\", \"Identical\", or \"Partial Overlap\".">
##INFO=<ID=Name,Number=.,Type=String,Description="DGV Gene Name">
##INFO=<ID=Frequency,Number=.,Type=Float,Description="Samples Count / Num. of Unique Samples">
##INFO=<ID=Type2,Number=1,Type=String,Description="Gain or Loss">
##INFO=<ID=Region2,Number=.,Type=String,Description="The genomic position of the region.">
##INFO=<ID=Span3,Number=.,Type=Integer,Description="The size of the region (Stop-Stop).">
##INFO=<ID=OverlapType2,Number=1,Type=String,Description="Specifies the way in which the CNV overlaps the region. Either \"Contains Region\", \"Within Region\", \"Identical\", or \"Partial Overlap\".">
##INFO=<ID=Type3,Number=1,Type=String,Description="">
##INFO=<ID=Frequency2,Number=.,Type=Float,Description="">
##INFO=<ID=DeletionFrequency,Number=.,Type=Float,Description="">
##INFO=<ID=DuplicationFrequency,Number=.,Type=Float,Description="">
##FORMAT=<ID=CNVState,Number=1,Type=String,Description="State of the CNV event for each sample">
##FORMAT=<ID=AvgTargetMeanDepth,Number=1,Type=Float,Description="Average mean depth of the targets in this event as reported by Coverage Statistics">
##FORMAT=<ID=AvgZScore,Number=1,Type=Float,Description="Average Z-score of the targets in this event">
##FORMAT=<ID=AvgRatio,Number=1,Type=Float,Description="Average ratio of the targets in this event">
##FORMAT=<ID=pvalue,Number=1,Type=Float,Description="Probability that z-scores at least as extreme as those in the event would occur by chance in a normal region.">
##FORMAT=<ID=GeneList,Number=.,Type=String,Description="The genes that the cnv overlaps">
##FORMAT=<ID=CriticalGeneList,Number=.,Type=String,Description="The critical genes that the cnvs overlaps, these genes have established evidence for HI/TS. HI/TS maybe come from genes and regions in clingen or from the internal catalog of gene evaluations.">
##FORMAT=<ID=ScoredGene,Number=.,Type=String,Description="The gene with the maximum score for the gene specific criteria from the critical gene list. This gene has the strongest known effect.">
##FORMAT=<ID=ScoredGeneTranscript,Number=.,Type=String,Description="The transcript for the gene that was scored">
##FORMAT=<ID=Classification,Number=1,Type=String,Description="Classification of the score, this catagorizes the score to it pathogenicity based on the thresholds of Benign: score <= -1, Likely Benign: -1 < score <= -0.9, VUS: -0.9 < score < 0.9, Likely Pathogenic: 0.9 <= score < 1, Pathogenic: score <= 1.">
##FORMAT=<ID=Criteria,Number=.,Type=String,Description="The list of all of the criteria that were applied to reach the 'Total Score' and as a result the 'Classification'.">
##INFO=<ID=END,Number=1,Type=Integer,Description="">
##FORMAT=<ID=GT,Number=1,Type=String,Description="">
##FORMAT=<ID=CN,Number=1,Type=Integer,Description="">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO	FORMAT	H147-301222-ROCHE_S95_R
1	23798107	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=1;Span=2375;GeneNames=GALE;GeneIDs=2582;Aliases=SDR1E1;Genes=1;TranscriptNameClinicallyRelevant=NM_000403.4;OverlappingExonsClinicallyRelevant=1-5;HGVSg=NC_000001.11:g.23798107_23800481dup;HGVScClinicallyRelevant=NM_000403.4:c.1_351+10dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(1)p36.11;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=23800481	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:82.2937:2.72065:1.35569:2.49983250769608e-05:GALE::GALE:NM_000403.4:VUS:2L0ThiscnvpartiallyoverlapstheGALEgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	24346537	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=1;Span=3614;GeneNames=GRHL3;GeneIDs=57822;Aliases=SOM,TFCP2L4,VWS2;Genes=1;TranscriptNameClinicallyRelevant=NM_198173.3;OverlappingExonsClinicallyRelevant=13-15;HGVSg=NC_000001.11:g.24346537_24350150dup;HGVScClinicallyRelevant=NM_198173.3:c.1455-16_1694+28dup;HGVSpClinicallyRelevant=NP_937816.1:p.L486_G565dup;ISCNCytobandNotation=dup(1)p36.11;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=24350150	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:89.1028:2.92954:1.44987:8.56351676119484e-05:GRHL3::GRHL3:NM_198173.3:VUS:2L0ThiscnvpartiallyoverlapstheGRHL3genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	28010956	.	N	<DEL>	.	.	Type=Loss;Targets=1;Samples2=1;Span=120;GeneNames=EYA3;GeneIDs=2140;Genes=1;TranscriptNameClinicallyRelevant=NM_001990.4;OverlappingExonsClinicallyRelevant=10;HGVSg=NC_000001.11:g.28010956_28011075del;HGVScClinicallyRelevant=NM_001990.4:c.781_900del;HGVSpClinicallyRelevant=NP_001981.2:p.T261_S300del;ISCNCytobandNotation=del(1)p35.3;SequenceOntologyClinicallyRelevant=inframe_deletion;RegionClinicallyRelevant=exon;END=28011075	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:22.2417:-4.76179:0.344653:0.000218366724908823:EYA3::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes:1
1	31667542	.	N	<DUP>	.	.	Type=Gain;Targets=5;Samples2=1;Span=4156;GeneNames=COL16A1;GeneIDs=1307;Aliases=447AA,FP1572;Genes=1;TranscriptNameClinicallyRelevant=NM_001856.4;OverlappingExonsClinicallyRelevant=48-52;HGVSg=NC_000001.11:g.31667542_31671697dup;HGVScClinicallyRelevant=NM_001856.4:c.3106-38_3357+33dup;HGVSpClinicallyRelevant=NP_001847.3:p.M1040_G1123dup;ISCNCytobandNotation=dup(1)p35.2;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=31671697	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:82.84:3.11832:1.41378:6.18754839245295e-08:COL16A1:COL16A1:COL16A1:NM_001856.4:VUS:3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	46572055	.	N	<DUP>	.	.	Type=Gain;Targets=5;Samples2=4;Span=11283;GeneNames=MKNK1;GeneIDs=8569;Aliases=MNK1;Genes=1;TranscriptNameClinicallyRelevant=NM_001135553.4;OverlappingExonsClinicallyRelevant=3-7;HGVSg=NC_000001.11:g.46572055_46583337dup;HGVScClinicallyRelevant=NM_001135553.4:c.1_457+8dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(1)p33;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=46583337	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:82.2433:2.63826:1.38764:4.81443016572332e-06:MKNK1::MKNK1:NM_001135553.4:VUS:2L0ThiscnvpartiallyoverlapstheMKNK1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	84929559	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=MCOLN2;GeneIDs=255231;Aliases=TRP-ML2,TRPML2;Genes=1;TranscriptNameClinicallyRelevant=NM_153259.4;OverlappingExonsClinicallyRelevant=13;HGVSg=NC_000001.11:g.84929559_84929678dup;HGVScClinicallyRelevant=NM_153259.4:c.1663_1664ins(120);HGVSpClinicallyRelevant=NP_694991.2:p.K515_R554dup;ISCNCytobandNotation=dup(1)p22.3;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=84929678	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:88.2083:4.76495:1.61266:0.000225146668418828:MCOLN2::MCOLN2:NM_153259.4:VUS:2L0ThiscnvpartiallyoverlapstheMCOLN2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	100038215	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=2;Span=120;GeneNames=MFSD14A;GeneIDs=64645;Aliases=HIAT1;Genes=1;TranscriptNameClinicallyRelevant=NM_033055.3;OverlappingExonsClinicallyRelevant=1;HGVSg=NC_000001.11:g.100038215_100038334dup;HGVScClinicallyRelevant=NM_033055.3:c.1_84+18dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(1)p21.2;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=100038334	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:142.35:5.91426:1.68238:4.41651369018819e-06:MFSD14A::MFSD14A:NM_033055.3:VUS:2L0ThiscnvpartiallyoverlapstheMFSD14Agenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	109114174	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=47841;GeneNames=ELAPOR1;GeneIDs=57535;Aliases=EIG121,KIAA1324;Genes=1;TranscriptNameClinicallyRelevant=NM_020775.5;OverlappingExonsClinicallyRelevant=1-2;HGVSg=NC_000001.11:g.109114174_109162014dup;HGVScClinicallyRelevant=NM_020775.5:c.1_274dup;HGVSpClinicallyRelevant=NP_065826.3:p.S92Yfs*3;ISCNCytobandNotation=dup(1)p13.3;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;Region2=1:109061620-109239599;Span3=177980;OverlapType2=Within Region;Type3=Duplication;Frequency2=0.000168947;DeletionFrequency=0;DuplicationFrequency=0.000168947;END=109162014	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:115.44:3.64924:1.44624:6.39483232785753e-05:ELAPOR1::ELAPOR1:NM_020775.5:VUS:2L0ThiscnvpartiallyoverlapstheELAPOR1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	155731928	.	N	<DEL>	.	.	Type=Loss;Targets=3;Samples2=1;Span=6332;GeneNames=DAP3;GeneIDs=7818;Aliases=DAP-3,MRP-S29,MRPS29,S29mt,bMRP-10;Genes=1;TranscriptNameClinicallyRelevant=NM_004632.4;OverlappingExonsClinicallyRelevant=11-13;HGVSg=NC_000001.11:g.155731928_155738259del;HGVScClinicallyRelevant=NM_004632.4:c.904-16_1197del;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=del(1)q22;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=155738259	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:40.6139:-2.78257:0.615104:0.00017974299180466:DAP3::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes:1
1	204997161	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=1;Span=4128;GeneNames=NFASC;GeneIDs=23114;Aliases=NEDCPMD,NF,NRCAML;Genes=1;TranscriptNameClinicallyRelevant=NM_001005388.3;OverlappingExonsClinicallyRelevant=25-26;HGVSg=NC_000001.11:g.204997161_205001288dup;HGVScClinicallyRelevant=NM_001005388.3:c.2783-9_3136+2dup;HGVSpClinicallyRelevant=NP_001005388.2:p.D1045_S1046ins118;ISCNCytobandNotation=dup(1)q32.1;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=205001288	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:145.233:3.28151:1.38177:1.05140164029499e-05:NFASC::NFASC:NM_001005388.3:VUS:2L0ThiscnvpartiallyoverlapstheNFASCgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
2	95593974	.	N	<DEL>	.	.	Type=Loss;Targets=5;Samples2=10;Span=2468;GeneNames=TRIM43;GeneIDs=129868;Aliases=TRIM43A;Genes=1;TranscriptNameClinicallyRelevant=NM_138800.3;OverlappingExonsClinicallyRelevant=2-4;HGVSg=NC_000002.12:g.95593974_95596441del;HGVScClinicallyRelevant=NM_138800.3:c.1_738+9del;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=del(2)q11.1;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=95596441	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:48.4792:-2.72185:0.577349:2.11564199027663e-06:TRIM43::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes:1
2	106065744	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=2;Span=5279;GeneNames=ECRG4;GeneIDs=84417;Aliases=C2orf40;Genes=1;TranscriptNameClinicallyRelevant=NM_032411.3;OverlappingExonsClinicallyRelevant=1;HGVSg=NC_000002.12:g.106065744_106071022dup;HGVScClinicallyRelevant=NM_032411.3:c.1_80-822dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(2)q12.2;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=106071022	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:70.625:3.66482:1.66201:5.94345158434474e-05:ECRG4::ECRG4:NM_032411.3:VUS:2L0ThiscnvpartiallyoverlapstheECRG4genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
2	219462282	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=SPEG;GeneIDs=10290;Aliases=APEG-1,APEG1,BPEG,CNM5,MYLK6,SPEGalpha,SPEGbeta;Genes=1;TranscriptNameClinicallyRelevant=NM_005876.5;OverlappingExonsClinicallyRelevant=8;HGVSg=NC_000002.12:g.219462282_219462401dup;HGVScClinicallyRelevant=NM_005876.5:c.2617-16_2705+15dup;HGVSpClinicallyRelevant=NP_005867.3:p.L903Sfs*8;ISCNCytobandNotation=dup(2)q35;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=219462401	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:126.583:5.20362:1.65637:5.4957306974369e-05:SPEG::SPEG:NM_005876.5:VUS:2L0ThiscnvpartiallyoverlapstheSPEGgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
2	240480928	.	N	<DUP>	.	.	Type=Gain;Targets=9;Samples2=1;Span=39241;GeneNames=ANKMY1;GeneIDs=51281;Aliases=ZMYND13;Genes=1;TranscriptNameClinicallyRelevant=NM_001282771.3;OverlappingExonsClinicallyRelevant=10-17;HGVSg=NC_000002.12:g.240480928_240520168dup;HGVScClinicallyRelevant=NM_001282771.3:c.2004+194_3046+9dup;HGVSpClinicallyRelevant=NP_001269700.1:p.V1016Afs;ISCNCytobandNotation=dup(2)q37.3;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;Region=2:240482405-240575049;Span2=92645;OverlapType=Partial Overlap;Name=gssvG22418;Frequency=0.0006;Type2=Gain;END=240520168	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:138.086:2.38159:1.23148:2.95739909555479e-08:ANKMY1::ANKMY1:NM_001282771.3:VUS:2L0ThiscnvpartiallyoverlapstheANKMY1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
3	43055423	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=972;GeneNames=GASK1A;GeneIDs=729085;Aliases=C3orf41,FAM198A;Genes=1;TranscriptNameClinicallyRelevant=NM_001129908.3;OverlappingExonsClinicallyRelevant=4-5;HGVSg=NC_000003.12:g.43055423_43056394dup;HGVScClinicallyRelevant=NM_001129908.3:c.1414-9_1728dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(3)p22.1;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=43056394	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:143.022:3.62599:1.42754:7.12910263917582e-05:GASK1A::GASK1A:NM_001129908.3:VUS:2L0ThiscnvpartiallyoverlapstheGASK1Agenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
3	165074539	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=SI;GeneIDs=6476;Genes=1;TranscriptNameClinicallyRelevant=NM_001041.4;OverlappingExonsClinicallyRelevant=3;HGVSg=NC_000003.12:g.165074539_165074658dup;HGVScClinicallyRelevant=NM_001041.4:c.247_248ins(120);HGVSpClinicallyRelevant=NP_001032.2:p.F82_P83ins40;ISCNCytobandNotation=dup(3)q26.1;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=165074658	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:119.05:5.09741:1.60186:7.81148133899809e-05:SI::SI:NM_001041.4:VUS:2L0ThiscnvpartiallyoverlapstheSIgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
4	143997527	.	N	<DEL>	.	.	Type=Loss;Targets=4;Samples2=1;Span=3767;GeneNames=GYPB;GeneIDs=2994;Aliases=CD235b,GPB,GYP,MNS,PAS-3,SS;Genes=1;TranscriptNameClinicallyRelevant=NM_002100.6;OverlappingExonsClinicallyRelevant=2-4;HGVSg=NC_000004.12:g.143997527_144001293del;HGVScClinicallyRelevant=NM_002100.6:c.38-10_270+13del;HGVSpClinicallyRelevant=NP_002091.4:p.E13Gfs*43;ISCNCytobandNotation=del(4)q31.21;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=144001293	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:61.4:-3.52512:0.577466:3.89443179107216e-08:GYPB::.:.:Benign:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:1
5	14678668	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=6;Span=120;GeneNames=OTULIN;GeneIDs=90268;Aliases=AIPDS,FAM105B,GUM;Genes=1;TranscriptNameClinicallyRelevant=NM_138348.6;OverlappingExonsClinicallyRelevant=3;HGVSg=NC_000005.10:g.14678668_14678787dup;HGVScClinicallyRelevant=NM_138348.6:c.230-13_324+12dup;HGVSpClinicallyRelevant=NP_612357.4:p.G109Nfs*4;ISCNCytobandNotation=dup(5)p15.2;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=14678787	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:111.725:4.70553:1.96717:0.000270225465232433:OTULIN::OTULIN:NM_138348.6:VUS:2L0ThiscnvpartiallyoverlapstheOTULINgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
6	29829815	.	N	<DUP>	.	.	Type=Gain;Targets=10;Samples2=1;Span=115715;GeneNames=HCG4B,HCP5B,HLA-A,HLA-G,HLA-H;GeneIDs=3135,352990,3136,80868,3105;Aliases=MHC-G;Genes=5;TranscriptNameClinicallyRelevant=NR_001317.3,NR_031762.2,NM_002116.8,NM_001384290.1,NR_001434.4;OverlappingExonsClinicallyRelevant=All,All,All,5-7,All;HGVSg=NC_000006.12:g.29829815_29945529dup;HGVScClinicallyRelevant=.,.,.,NM_001384290.1:c.896-1_1017dup,.;HGVSpClinicallyRelevant=.,.,.,.,.;ISCNCytobandNotation=dup(6)p22.1;SequenceOntologyClinicallyRelevant=.,.,.,transcript_ablation,.;RegionClinicallyRelevant=.,.,.,exon,.;Region=6:29814237-29968417,6:29847832-29909182,6:29865090-29941052,6:29869295-29907959,6:29875077-29993638,6:29901673-29927473,6:29906350-29955370;Span2=154181,61351,75963,38665,118562,25801,49021;OverlapType=Within Region,Contains Region,Contains Region,Contains Region,Partial Overlap,Contains Region,Partial Overlap;Name=gssvG31951,gssvG31955,gssvG31954,gssvG31959,gssvG31952,gssvG31961,gssvG31957;Frequency=0.0107,0.0012,0.002,0.017,0.3134,0.0011,0.22;Type2=Gain,Gain,Gain,Gain,Gain,Gain,Gain;Region2=6:29686178-29960520,6:29708195-29950365,6:29825602-29865145,6:29869342-29907200;Span3=274343,242171,39544,37859;OverlapType2=Within Region,Within Region,Partial Overlap,Contains Region;Type3=Duplication,Duplication,Duplication,Duplication;Frequency2=1,0.825,0.025,0.025;DeletionFrequency=0,0,0,0;DuplicationFrequency=1,0.825,0.025,0.025;END=29945529	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:128.329:1.70723:1.73011:2.97337088313978e-05:HCG4B,HCP5B,HLA-A,HLA-G,HLA-H::HLA-G:NM_001384290.1:Benign:2L0ThiscnvpartiallyoverlapstheHLA-Ggenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
6	50847058	.	N	<DEL>	.	.	Type=Loss;Targets=1;Samples2=1;Span=120;GeneNames=TFAP2B;GeneIDs=7021;Aliases=AP-2B,AP-2beta,AP2-B,PDA2;Genes=1;TranscriptNameClinicallyRelevant=NM_003221.4;OverlappingExonsClinicallyRelevant=7;HGVSg=NC_000006.12:g.50847058_50847177del;HGVScClinicallyRelevant=.;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=del(6)p12.3;SequenceOntologyClinicallyRelevant=.;RegionClinicallyRelevant=.;END=50847177	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:18.425:-4.51243:0.368909:0.000463996259178452:TFAP2B:TFAP2B:TFAP2B:NM_003221.4:VUS:2D-10Thecnvoverlapsthe3'endoftheTFAP2BgenehoweveronlytheUTRregionisinvolved,1B-0.6TheCNVdoesnotoverlapthecodingregionofanygenes:1
9	114242150	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=1444;GeneNames=COL27A1;GeneIDs=85301;Aliases=STLS;Genes=1;TranscriptNameClinicallyRelevant=NM_032888.4;OverlappingExonsClinicallyRelevant=22-23;HGVSg=NC_000009.12:g.114242150_114243593dup;HGVScClinicallyRelevant=NM_032888.4:c.2836-37_2934+33dup;HGVSpClinicallyRelevant=NP_116277.2:p.D947_G979dup;ISCNCytobandNotation=dup(9)q32;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=114243593	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:126.95:4.15635:1.47048:5.11066129168948e-06:COL27A1::COL27A1:NM_032888.4:VUS:2L0ThiscnvpartiallyoverlapstheCOL27A1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
9	121327299	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=192;GeneNames=GSN;GeneIDs=2934;Aliases=ADF,AGEL;Genes=1;TranscriptNameClinicallyRelevant=NM_000177.5;OverlappingExonsClinicallyRelevant=13;HGVSg=NC_000009.12:g.121327299_121327490dup;HGVScClinicallyRelevant=NM_000177.5:c.1741-9_1915+8dup;HGVSpClinicallyRelevant=NP_000168.1:p.D639Gfs*4;ISCNCytobandNotation=dup(9)q33.2;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=121327490	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:123.818:5.00818:1.67284:0.000104434899462549:GSN::GSN:NM_000177.5:VUS:2L0ThiscnvpartiallyoverlapstheGSNgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
9	134822955	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=548;GeneNames=COL5A1,LOC101448202;GeneIDs=1289,101448202;Aliases=EDSC,EDSCL1,FMDMF;Genes=2;TranscriptNameClinicallyRelevant=NM_000093.5,NR_103451.2;OverlappingExonsClinicallyRelevant=60-61,.;HGVSg=NC_000009.12:g.134822955_134823502dup;HGVScClinicallyRelevant=NM_000093.5:c.4609-43_4698+33dup,.;HGVSpClinicallyRelevant=NP_000084.3:p.P1541_G1570dup,.;ISCNCytobandNotation=dup(9)q34.3;SequenceOntologyClinicallyRelevant=inframe_insertion,.;RegionClinicallyRelevant=exon,.;END=134823502	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:112.787:3.36622:1.41675:0.000230141405629668:COL5A1,LOC101448202:COL5A1:COL5A1:NM_000093.5:VUS:2I0ThevarianthasanunknownimpactontheCOL5A1geneoritisnotpredictedtoundergoNMD.,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
9	136971477	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=1;Span=7934;GeneNames=LINC02692,PTGDS;GeneIDs=101928638,5730;Aliases=C9orf141,PRR31;Genes=2;TranscriptNameClinicallyRelevant=NR_157392.1,NM_000954.6;OverlappingExonsClinicallyRelevant=4-5,1-3;HGVSg=NC_000009.12:g.136971477_136979410dup;HGVScClinicallyRelevant=.,NM_000954.6:c.1_331+111dup;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(9)q34.3;SequenceOntologyClinicallyRelevant=.,transcript_ablation;RegionClinicallyRelevant=.,exon;END=136979410	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:132.097:2.81709:1.29898:1.26502311232456e-05:LINC02692,PTGDS::PTGDS:NM_000954.6:VUS:2L0ThiscnvpartiallyoverlapsthePTGDSgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
10	3141613	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=2;Span=120;GeneNames=PITRM1,PITRM1-AS1;GeneIDs=10531,100507034;Aliases=MP1,PreP,SCAR30;Genes=2;TranscriptNameClinicallyRelevant=NM_001242309.1,NR_038284.1;OverlappingExonsClinicallyRelevant=.,1;HGVSg=NC_000010.11:g.3141613_3141732dup;HGVScClinicallyRelevant=NM_001242309.1:c.2352-801_2352-800ins(120),.;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(10)p15.2;SequenceOntologyClinicallyRelevant=intron_variant,.;RegionClinicallyRelevant=intron,.;END=3141732	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:109.608:4.58645:1.64724:0.000387185834972057:PITRM1,PITRM1-AS1::PITRM1:NM_001242309.1:VUS:2L0ThiscnvpartiallyoverlapsthePITRM1genewhichhasunknownclinicalsignificance,1B-0.6TheCNVdoesnotoverlapthecodingregionofanygenes:3
11	2313645	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=TSPAN32;GeneIDs=10077;Aliases=PHEMX,PHMX,TSSC6;Genes=1;TranscriptNameClinicallyRelevant=NM_139022.3;OverlappingExonsClinicallyRelevant=5;HGVSg=NC_000011.10:g.2313645_2313764dup;HGVScClinicallyRelevant=NM_139022.3:c.355-9_456+9dup;HGVSpClinicallyRelevant=NP_620591.3:p.V119_V152dup;ISCNCytobandNotation=dup(11)p15.5;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=2313764	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:123.042:5.47561:1.60663:2.1678046482865e-05:TSPAN32::TSPAN32:NM_139022.3:VUS:2L0ThiscnvpartiallyoverlapstheTSPAN32genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
11	117228223	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=4;Span=1630;GeneNames=PCSK7;GeneIDs=9159;Aliases=LPC,PC7,PC8,SPC7;Genes=1;TranscriptNameClinicallyRelevant=NM_004716.4;OverlappingExonsClinicallyRelevant=3-4;HGVSg=NC_000011.10:g.117228223_117229852dup;HGVScClinicallyRelevant=NM_004716.4:c.1_596dup;HGVSpClinicallyRelevant=NP_004707.2:p.N200Cfs*25;ISCNCytobandNotation=dup(11)q23.3;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=117229852	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:146.847:3.72071:1.36538:4.56079549299733e-05:PCSK7::PCSK7:NM_004716.4:VUS:2L0ThiscnvpartiallyoverlapsthePCSK7genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
12	53503700	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=1;Span=1116;GeneNames=TARBP2;GeneIDs=6895;Aliases=LOQS,TRBP,TRBP1,TRBP2;Genes=1;TranscriptNameClinicallyRelevant=NM_134323.2;OverlappingExonsClinicallyRelevant=4-6;HGVSg=NC_000012.12:g.53503700_53504815dup;HGVScClinicallyRelevant=NM_134323.2:c.327-13_613dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(12)q13.13;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=53504815	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:109.542:3.31147:1.35525:8.7076161934328e-06:TARBP2::TARBP2:NM_134323.2:VUS:2L0ThiscnvpartiallyoverlapstheTARBP2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
12	57610568	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=1;Span=2586;GeneNames=ARHGEF25;GeneIDs=115557;Aliases=GEFT,p63RhoGEF;Genes=1;TranscriptNameClinicallyRelevant=NM_182947.4;OverlappingExonsClinicallyRelevant=1-2;HGVSg=NC_000012.12:g.57610568_57613153dup;HGVScClinicallyRelevant=NM_182947.4:c.1_312+9dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(12)q13.3;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=57613153	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:87.4337:2.8867:1.3909:0.000108922875151751:ARHGEF25::ARHGEF25:NM_182947.4:VUS:2L0ThiscnvpartiallyoverlapstheARHGEF25genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
12	65963208	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=HMGA2;GeneIDs=8091;Aliases=BABL,HMGI-C,HMGIC,LIPO,SRS5,STQTL9;Genes=1;TranscriptNameClinicallyRelevant=NM_003483.6;OverlappingExonsClinicallyRelevant=5;HGVSg=NC_000012.12:g.65963208_65963327dup;HGVScClinicallyRelevant=NM_003483.6:c.283-37_330dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(12)q14.3;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=65963327	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:80.7833:5.26879:1.6696:4.41493976615288e-05:HMGA2::HMGA2:NM_003483.6:VUS:2L0ThiscnvpartiallyoverlapstheHMGA2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
14	105907139	.	N	<DEL>	.	.	Type=Loss;Targets=6;Samples2=20;Span=7272;Region=14:105895622-105912944,14:105904771-105917142;Span2=17323,12372;OverlapType=Partial Overlap,Within Region;Name=gssvL37273,gssvL37314;Frequency=0.1145,0.0417;Type2=Loss,Loss;Region2=14:105895696-105916947,14:105907304-105916494,14:105908863-105910510,14:105908955-105910510;Span3=21252,9191,1648,1556;OverlapType2=Within Region,Partial Overlap,Contains Region,Contains Region;Type3=Deletion,Deletion,Deletion,Deletion;Frequency2=0.325,0.1,0.00236686,0.00118343;DeletionFrequency=0.325,0.1,0.00236686,0.00118343;DuplicationFrequency=0,0,0,0;END=105914410	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Deletion:0:-1.9755:0:0.000166660979997113:::.:.:Benign:1B-0.6TheCNVdoesnotoverlapanygenes,2F-1ThecnviscompletelycontainedinthehaplobenignregionISCA-37477inClinGenDosageSensitivity.,3A0Thiscnvoverlaps0proteincodinggenes:0
16	2936319	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=FLYWCH1;GeneIDs=84256;Genes=1;TranscriptNameClinicallyRelevant=NM_001308068.2;OverlappingExonsClinicallyRelevant=.;HGVSg=NC_000016.10:g.2936319_2936438dup;HGVScClinicallyRelevant=NM_001308068.2:c.1514-803_1514-802ins(120);HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(16)p13.3;SequenceOntologyClinicallyRelevant=intron_variant;RegionClinicallyRelevant=intron;END=2936438	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:136.108:4.91533:1.6577:0.000140586668274777:FLYWCH1::FLYWCH1:NM_001308068.2:VUS:2L0ThiscnvpartiallyoverlapstheFLYWCH1genewhichhasunknownclinicalsignificance,1B-0.6TheCNVdoesnotoverlapthecodingregionofanygenes:3
16	4726660	.	N	<DUP>	.	.	Type=Gain;Targets=5;Samples2=1;Span=11337;GeneNames=ANKS3,DNAAF8;GeneIDs=124401,146562;Genes=2;TranscriptNameClinicallyRelevant=NM_133450.4,NM_139170.3;OverlappingExonsClinicallyRelevant=1-5,1-3;HGVSg=NC_000016.10:g.4726660_4737996dup;HGVScClinicallyRelevant=NM_133450.4:c.1_490dup,NM_139170.3:c.1_276+50dup;HGVSpClinicallyRelevant=NP_597707.1:p.R164Nfs*7,.;ISCNCytobandNotation=dup(16)p13.3;SequenceOntologyClinicallyRelevant=frameshift_variant,transcript_ablation;RegionClinicallyRelevant=exon,exon;END=4737996	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:118.207:2.76401:1.33167:1.64338814675141e-06:ANKS3,DNAAF8::ANKS3:NM_133450.4:VUS:2L0ThiscnvpartiallyoverlapstheANKS3genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
16	8795942	.	N	<DUP>	.	.	Type=Gain;Targets=9;Samples2=1;Span=17167;GeneNames=PMM2,TMEM186;GeneIDs=25880,5373;Aliases=C16orf51;Genes=2;TranscriptNameClinicallyRelevant=NM_000303.3,NM_015421.4;OverlappingExonsClinicallyRelevant=1-7,All;HGVSg=NC_000016.10:g.8795942_8813108dup;HGVScClinicallyRelevant=NM_000303.3:c.1_639+2dup,.;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(16)p13.2;SequenceOntologyClinicallyRelevant=transcript_ablation,.;RegionClinicallyRelevant=exon,.;Region=16:8773500-8821048;Span2=47549;OverlapType=Within Region;Name=gssvG14043;Frequency=0.0005;Type2=Gain;Region2=16:8795772-8821048,16:8804848-8828534;Span3=25277,23687;OverlapType2=Within Region,Partial Overlap;Type3=Duplication,Duplication;Frequency2=0.000168947,0.00118343;DeletionFrequency=0,0;DuplicationFrequency=0.000168947,0.00118343;END=8813108	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:155.238:2.82591:1.24665:4.50665259982787e-11:PMM2,TMEM186::PMM2:NM_000303.3:VUS:2L0ThiscnvpartiallyoverlapsthePMM2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
16	22008295	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=8;Span=72594;GeneNames=MOSMO;GeneIDs=730094;Aliases=ATTHOG,BC030336,C16orf52;Genes=1;TranscriptNameClinicallyRelevant=NM_001164579.2;OverlappingExonsClinicallyRelevant=All;HGVSg=NC_000016.10:g.22008295_22080888dup;HGVScClinicallyRelevant=.;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(16)p12.2;SequenceOntologyClinicallyRelevant=.;RegionClinicallyRelevant=.;END=22080888	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:109.373:2.50978:1.3896:0.000102812460829043:MOSMO::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes:3
16	22118904	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=1;Span=4281;GeneNames=VWA3A;GeneIDs=146177;Genes=1;TranscriptNameClinicallyRelevant=NM_173615.5;OverlappingExonsClinicallyRelevant=12-15;HGVSg=NC_000016.10:g.22118904_22123184dup;HGVScClinicallyRelevant=NM_173615.5:c.993_1437+19dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(16)p12.2;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=22123184	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:93.8104:2.33263:1.37525:0.000311644066386772:VWA3A::VWA3A:NM_173615.5:VUS:2L0ThiscnvpartiallyoverlapstheVWA3Agenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
16	29384148	.	N	<DEL>	.	.	Type=Loss;Targets=4;Samples2=1;Span=6207;GeneNames=NPIPB11;GeneIDs=728888;Aliases=NPIP;Genes=1;TranscriptNameClinicallyRelevant=NM_001310137.5;OverlappingExonsClinicallyRelevant=4-8;HGVSg=NC_000016.10:g.29384148_29390354del;HGVScClinicallyRelevant=NM_001310137.5:c.250-6_784del;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=del(16)p11.2;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=29390354	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:40.8896:-2.86604:0.531262:8.0705196750681e-06:NPIPB11::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes:1
17	8911384	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=6;Span=120;GeneNames=PIK3R5;GeneIDs=23533;Aliases=F730038I15Rik,FOAP-2,P101-PI3K,p101;Genes=1;TranscriptNameClinicallyRelevant=NM_001142633.3;OverlappingExonsClinicallyRelevant=2;HGVSg=NC_000017.11:g.8911384_8911503dup;HGVScClinicallyRelevant=NM_001142633.3:c.1_103+8dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(17)p13.1;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=8911503	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:101.45:4.65654:1.66892:0.000313629299441524:PIK3R5::PIK3R5:NM_001142633.3:VUS:2L0ThiscnvpartiallyoverlapsthePIK3R5genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
17	40978186	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=KRT40;GeneIDs=125115;Aliases=CK-40,K40,KA36;Genes=1;TranscriptNameClinicallyRelevant=NM_001389244.1;OverlappingExonsClinicallyRelevant=7;HGVSg=NC_000017.11:g.40978186_40978305dup;HGVScClinicallyRelevant=NM_001389244.1:c.1197-9_1296dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(17)q21.2;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=40978305	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:85.0333:4.51473:1.66098:0.000478948064921869:KRT40::KRT40:NM_001389244.1:VUS:2L0ThiscnvpartiallyoverlapstheKRT40genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
18	63556151	.	N	<DEL>	.	.	Type=Loss;Targets=3;Samples2=3;Span=3577;GeneNames=SERPINB12;GeneIDs=89777;Aliases=YUKOPIN;Genes=1;TranscriptNameClinicallyRelevant=NM_001307928.2;OverlappingExonsClinicallyRelevant=2-4;HGVSg=NC_000018.10:g.63556151_63559727del;HGVScClinicallyRelevant=NM_001307928.2:c.1_444+9del;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=del(18)q21.33;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=63559727	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:58.8803:-4.24531:0.565725:9.97552133976997e-09:SERPINB12::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes:1
19	10587150	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=3;Span=39187;GeneNames=AP1M2,SLC44A2;GeneIDs=10053,57153;Aliases=AP1-mu2,HSMU1B,MU-1B,MU1B,mu2;Genes=2;TranscriptNameClinicallyRelevant=NM_005498.5,NM_020428.4;OverlappingExonsClinicallyRelevant=1,1-2;HGVSg=NC_000019.10:g.10587150_10626336dup;HGVScClinicallyRelevant=NM_005498.5:c.1_42+40dup,NM_020428.4:c.1_86+35dup;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(19)p13.2;SequenceOntologyClinicallyRelevant=transcript_ablation,transcript_ablation;RegionClinicallyRelevant=exon,exon;END=10626336	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:102.515:2.51755:1.35938:9.77714583777329e-05:AP1M2,SLC44A2::AP1M2:NM_005498.5:VUS:2L0ThiscnvpartiallyoverlapstheAP1M2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
19	51327080	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=1;Span=5605;GeneNames=IGLON5,VSIG10L;GeneIDs=402665,147645;Genes=2;TranscriptNameClinicallyRelevant=NM_001101372.3,NM_001163922.3;OverlappingExonsClinicallyRelevant=6-8,10;HGVSg=NC_000019.10:g.51327080_51332684dup;HGVScClinicallyRelevant=NM_001101372.3:c.647_1011dup,NM_001163922.3:c.2575-44_2604dup;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(19)q13.41;SequenceOntologyClinicallyRelevant=3_prime_UTR_variant,transcript_ablation;RegionClinicallyRelevant=UTR3,exon;END=51332684	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:114.485:2.74586:1.32499:2.09645472564867e-05:IGLON5,VSIG10L::IGLON5:NM_001101372.3:VUS:2L0ThiscnvpartiallyoverlapstheIGLON5genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
